EKTA MAKANI: Open Payments
NPI 1689156291 · ISELIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 34 payments from 17 companies in 2025. Trend: 2023 $82 · 2024 $623 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $310 |
| Novo Nordisk Inc | 3 | $51 |
| Exact Sciences Corporation | 2 | $46 |
| Amgen Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| ABBVIE INC. | 2 | $29 |
| Lilly USA, LLC | 2 | $29 |
| Astellas Pharma US Inc | 1 | $22 |
Products named: FARXIGA, BREZTRI, Wegovy, The Cologuard Plus Collection Kit, OTEZLA, JARDIANCE, AIRSUPRA, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
